pipeline biospace - Robuta Search

https://www.biospace.com/drug-development/biogens-lupus-drug-reduces-disease-activity-further-de-risking-i-i-pipeline Biogen's Lupus Drug Reduces Disease Activity, Further Deresking I&I Pipeline - BioSpace Mar 30, 2026 - William Blair hailed a positive readout in cutaneous lupus erythematosus as a turning point for Biogen, while RBC Capital analysts called the results “another... disease activity pipeline biospace biogen lupus drug https://www.biospace.com/pipeline Pipeline - BioSpace pipeline biospace https://www.biospace.com/business/biogens-bridge-to-growth-cuts-through-a-stacked-phase-3-pipeline Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline - BioSpace Feb 6, 2026 - With Biogen’s multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage pipeline and hunting for deals to... phase 3 pipeline biospace cuts stacked https://www.biospace.com/drug-development/daiichi-sankyo-dumps-next-gen-adc-from-development-pipeline Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline - BioSpace Feb 3, 2026 - DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload. daiichi sankyo next gen development pipeline dumps adc https://www.biospace.com/business/biontech-starts-shuttering-singapore-mrna-manufacturing-site-amid-pipeline-pivot BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot - BioSpace Apr 3, 2026 - BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other modalities while mRNA technology... manufacturing site biontech starts shuttering singapore https://www.biospace.com/drug-development/pharma-pipeline-stalls-for-first-time-in-decades-citeline Pharma Pipeline Stalls for First Time in Decades: Citeline - BioSpace Apr 6, 2026 - Some disease areas bucked the trend of shrinking pipelines, however, with immune and cardiovascular indications seeing an upward trend in investigational... first time pharma pipeline stalls decades https://www.biospace.com/business/pharma-r-d-spend-drops-3-6-as-pipeline-prioritizations-take-shape Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape - BioSpace Mar 25, 2026 - Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 billion the year prior. Here’s... pharma r drops 3 take shape spend 6 https://www.biospace.com/deals/lilly-bulks-up-inflammatory-pipeline-with-1-2b-ventyx-buy-indupro-cancer-pact Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact - BioSpace Jan 8, 2026 - The deals will help Lilly diversify its portfolio that is heavily weighted on the obesity juggernaut tirzepatide, marketed as Mounjaro for diabetes and... 1 2b lilly bulks inflammatory pipeline https://www.biospace.com/business/ipo-tracker-2026 Avalyn plots IPO to push inhaled pulmonary fibrosis pipeline through clinic - BioSpace Apr 9, 2026 - Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this... pulmonary fibrosis avalyn plots ipo push